At SynBio We Are The Pharma Company of the Future.
Despite tech advancements, bringing a new drug to market remains a decade-long, billion-dollar endeavor. The time and costs of drug development continue to climb, leading to higher drug and healthcare costs, and making treatments less accessible for many. Our Pharmaceutical Sales Rep team can bring our model creates a radically more efficient approach across the drug distribution channels which ultimately bring pharmaceutical and biotech products faster than ever before so to bring treatments to patients.
There are several thousand known human diseases, yet we only have FDA-approved pharmaceutical and biotech treatments for about 500 of them. Patients are desperately waiting for more. We are building the pharma company of the future designed to bring new treatments to patients faster than ever before.
Despite the sweeping technological changes transforming biotech — and society at large — the process of bringing a new drug to market still lasts longer than 10 years, and costs billions of dollars. What’s more, the time and costs are actually increasing, contributing to rising drug prices, inflated healthcare costs, and, ultimately, decreased access to treatments for patients.